1. Home
  2. ARQT vs HI Comparison

ARQT vs HI Comparison

Compare ARQT & HI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • HI
  • Stock Information
  • Founded
  • ARQT 2016
  • HI 2007
  • Country
  • ARQT United States
  • HI United States
  • Employees
  • ARQT N/A
  • HI N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • HI Miscellaneous manufacturing industries
  • Sector
  • ARQT Health Care
  • HI Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • HI Nasdaq
  • Market Cap
  • ARQT 1.7B
  • HI 1.4B
  • IPO Year
  • ARQT 2020
  • HI N/A
  • Fundamental
  • Price
  • ARQT $15.76
  • HI $22.28
  • Analyst Decision
  • ARQT Strong Buy
  • HI Hold
  • Analyst Count
  • ARQT 6
  • HI 2
  • Target Price
  • ARQT $18.80
  • HI $24.00
  • AVG Volume (30 Days)
  • ARQT 2.0M
  • HI 533.8K
  • Earning Date
  • ARQT 08-13-2025
  • HI 08-06-2025
  • Dividend Yield
  • ARQT N/A
  • HI 4.04%
  • EPS Growth
  • ARQT N/A
  • HI N/A
  • EPS
  • ARQT N/A
  • HI N/A
  • Revenue
  • ARQT $212,819,000.00
  • HI $3,047,000,000.00
  • Revenue This Year
  • ARQT $61.01
  • HI N/A
  • Revenue Next Year
  • ARQT $37.95
  • HI N/A
  • P/E Ratio
  • ARQT N/A
  • HI N/A
  • Revenue Growth
  • ARQT 100.03
  • HI 0.30
  • 52 Week Low
  • ARQT $7.86
  • HI $18.36
  • 52 Week High
  • ARQT $17.75
  • HI $45.53
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 60.23
  • HI 56.38
  • Support Level
  • ARQT $13.06
  • HI $21.94
  • Resistance Level
  • ARQT $15.36
  • HI $23.60
  • Average True Range (ATR)
  • ARQT 0.66
  • HI 0.87
  • MACD
  • ARQT 0.12
  • HI 0.22
  • Stochastic Oscillator
  • ARQT 82.57
  • HI 68.87

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About HI Hillenbrand Inc

Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.

Share on Social Networks: